Cardiff Oncology Inc. (CRDF)

Business: Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California.

IPO Date: 27-Jul-2004

CEO & Director: Dr. Mark Erlander Ph.D.

Chief Financial Officer: Mr. James E. Levine

Listing: NASDAQ: CRDF

Country: United States

Headquarters: San Diego, CA

Website: https://www.cardiffoncology.com

Market cap: $96.14 Mln

Revenue (TTM): $0.36 Mln

Earnings (TTM): $-34.13 Mln

Cash: $129.36 Mln

Total Debt: $3.10 Mln

Insider's Holding: 7.12%

Liquidity: Low

52 Week range: $1.13 - 8.58

Shares outstanding: 43,306,100

10 Years Aggregate:

• CFO: $-167.24 Mln
• EBITDA: $-194.06 Mln
• Net Profit: $-209.76 Mln